Potential or contraindicated drug–drug interactions with antiretroviral therapy in real-world settings in Taiwan
Background/Purpose: Given the complex metabolic pathway of antiretroviral therapy (ART), polypharmacy may increase the risk of drug–drug interactions (DDIs). Therefore, we investigated the frequency of DDIs during ART exposure to improve medical care for patients with human immunodeficiency virus (H...
Main Authors: | Chi-Chuan Wang, Hsing-Jung Li, Chi-Hao Shao, Wang-Huei Sheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664621005520 |
Similar Items
-
Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
by: Charlotte Charpentier, et al.
Published: (2023-02-01) -
Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01) -
An appeal for large scale production of antiretroviral drugs in Africa
by: Nkamedjie Pete Patrick Martial, et al.
Published: (2016-09-01) -
Antiretroviral drug resistance among U.S. veterans living with human immunodeficiency virus 1
by: Rahul Mahapatra, et al.
Published: (2019-03-01) -
Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria
by: Muhammed O. Afolabi, et al.
Published: (2009-04-01)